Works matching DE "EPIRUBICIN"

Results: 513
    1
    2
    3
    4
    5
    6

    Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 8, p. e2429772, doi. 10.1001/jamanetworkopen.2024.29772
    By:
    • Joensuu, Heikki;
    • Fraser, Judith;
    • Wildiers, Hans;
    • Huovinen, Riikka;
    • Auvinen, Päivi;
    • Utriainen, Meri;
    • Villman, Kenneth K.;
    • Halonen, Päivi;
    • Granstam-Björneklett, Helena;
    • Tanner, Minna;
    • Sailas, Liisa;
    • Turpeenniemi-Hujanen, Taina;
    • Yachnin, Jeffrey;
    • Huttunen, Teppo;
    • Neven, Patrick;
    • Canney, Peter;
    • Harvey, Vernon J.;
    • Kellokumpu-Lehtinen, Pirkko-Liisa;
    • Lindman, Henrik
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane.

    Published in:
    Oncology Letters, 2017, v. 13, n. 1, p. 69, doi. 10.3892/ol.2016.5456
    By:
    • NOBUTAKA AOYAMA;
    • YASUHIRO OGAWA;
    • MIKI YASUOKA;
    • HITOMI IWASA;
    • KANA MIYATAKE;
    • RIKA YOSHIMATSU;
    • TOMOAKI YAMANISHI;
    • NORIHIKO HAMADA;
    • TAIJI TAMURA;
    • KANA KOBAYASHI;
    • YORIKO MURATA;
    • TAKUJI YAMAGAMI;
    • MITSUHIKO MIYAMURA
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Rapid and early α-fetoprotein and des-γ-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma.

    Published in:
    Molecular & Clinical Oncology, 2015, v. 3, n. 3, p. 655, doi. 10.3892/mco.2015.523
    By:
    • OYAMA, KENJI;
    • KODA, MASAHIKO;
    • SUGIHARA, TAKAAKI;
    • KISHINA, MANABU;
    • MIYOSHI, KENICHI;
    • OKAMOTO, TOSHIAKI;
    • HODOTSUKA, MASANORI;
    • FUJISE, YUKI;
    • MATONO, TOMOMITSU;
    • TOKUNAGA, SHIHO;
    • OKAMOTO, KINYA;
    • HOSHO, KEIKO;
    • OKANO, JUNICHI;
    • MURAWAKI, YOSHIKAZU
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    A Stereochemically Driven Supramolecular Polymerisation.

    Published in:
    Chemistry - A European Journal, 2018, v. 24, n. 32, p. 8195, doi. 10.1002/chem.201800644
    By:
    • Tasca, Elisamaria;
    • D'abramo, Marco;
    • Galantini, Luciano;
    • Giuliani, Anna Maria;
    • Pavel, Nicolae Viorel;
    • Palazzo, Gerardo;
    • Giustini, Mauro
    Publication type:
    Article
    42
    43
    44
    45

    Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5479, doi. 10.1007/s00432-022-04454-8
    By:
    • Rodriguez-Cid, Jeronimo Rafael;
    • Juarez-Vignon Whaley, Juan Jose;
    • Sánchez-Domínguez, Gisela;
    • Guzmán-Casta, Jordi;
    • Carrasco-CaraChards, Sonia;
    • Guzmán-Huesca, Jorge;
    • Riera-Sala, Rodrigo;
    • Sánchez-Ríos, Carla Paola;
    • Cruz-Zermeño, Mayte;
    • Seidman-Sorsby, Alec;
    • de Jesús Rodríguez-Zea, Ivan;
    • Alatorre-Alexander, Jorge Arturo;
    • Martínez-Barrera, Luis Manuel;
    • Santillán-Doherty, Patricio Javier;
    • Godina-Flores, Aminadab;
    • Imaz-Olguin, Victoria;
    • Sosa-Sánchez, Ricardo;
    • Green-Renner, Dan
    Publication type:
    Article
    46
    47
    48

    Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 1, p. 96, doi. 10.1007/s10120-017-0718-5
    By:
    • Carmona-Bayonas, A.;
    • Jiménez-Fonseca, P.;
    • Custodio, A.;
    • Sánchez Cánovas, M.;
    • Hernández, R.;
    • Pericay, C.;
    • Echavarria, I.;
    • Lacalle, A.;
    • Visa, L.;
    • Rodríguez Palomo, A.;
    • Mangas, M.;
    • Cano, J. M.;
    • Buxo, E.;
    • Álvarez-Manceñido, F.;
    • García, T.;
    • Lorenzo, J. E.;
    • Ferrer-Cardona, M.;
    • Viudez, A.;
    • Azkarate, A.;
    • Ramchandani, A.
    Publication type:
    Article
    49
    50

    Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer.

    Published in:
    Gastric Cancer, 2017, v. 20, n. 2, p. 358, doi. 10.1007/s10120-016-0618-0
    By:
    • Moehler, Markus;
    • Weinmann, Arndt;
    • Mansoor, Wasat;
    • Mahlberg, Rolf;
    • Heinemann, Volker;
    • Obermannová, Radka;
    • Kubala, Eugen;
    • Melichar, Bohuslav;
    • Scigalla, Paul;
    • Tesařová, Marietta;
    • Janda, Petr;
    • Hédouin-Biville, Fabienne
    Publication type:
    Article